PHAS
TD Asset Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-32,443
| Closed | -$149K | – | 1413 |
|
|
2020
Q2 | $149K | Hold |
32,443
| – | – | ﹤0.01% | 1302 |
|
|
2020
Q1 | $107K | Sell |
32,443
-11,400
| -26% | -$37.6K | ﹤0.01% | 1337 |
|
|
2019
Q4 | $268K | Buy |
43,843
+4,500
| +11% | +$27.5K | ﹤0.01% | 1334 |
|
|
2019
Q3 | $164K | Sell |
39,343
-1,000
| -2% | -$4.17K | ﹤0.01% | 1314 |
|
|
2019
Q2 | $529K | Buy |
40,343
+8,555
| +27% | +$112K | ﹤0.01% | 1173 |
|
|
2019
Q1 | $302K | Buy |
31,788
+600
| +2% | +$5.7K | ﹤0.01% | 1262 |
|
|
2018
Q4 | $96K | Buy |
+31,188
| New | +$96K | ﹤0.01% | 1378 |
|